TZ3O
Based on 1 Customer Validation
TZ3O is an anticholinergic agent with neuroprotective effects. TZ3O inhibits acetylcholinesterase (AChE) activity in human plasma with an IC50 of 304.5 μM. TZ3O can improve memory impairment and cognitive decline in rats in the Scopolamine (HY-N0296)-induced Alzheimer-type model. TZ3O could be used in Alzheimer’s research.
For research use only. We do not sell to patients.
- Purity: 98.17%
- Formula: C18H13NO4S
- Molecular Weight:339.37
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Neuronal Signaling Compound Library
HY-L013
-
Covalent Screening Library
HY-L036
-
Anti-Alzheimer's Disease Compound Library
HY-L069
-
Neuroprotective Compound Library
HY-L070
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Protease Inhibitor Library
HY-L147
-
Membrane Protein-targeted Compound Library
HY-L149
-
Highly Selective Inhibitors Library
HY-L158
-
Cell Death Library
HY-L162
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Covalent Screening Library Plus
HY-L036P
-
Bioactive Compound Library
HY-L001
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
All Caspase Isoforms
More
Biological Activity
|
AChE 304.5 μM (IC50) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Scopolamine (3 mg/kg, i.p.) was administered to adult male Wistar rats (250-300 g) to induce cholinergic neurotransmission disorder, constructing an Alzheimer’s disease model with memory and cognitive impairment[1]
-
Dosage:0.5, 1, 2, 4 mg/kg
-
Administration:i.p., 60 min before trials, 8 days total with 2 rest days
-
Result:Reduced escape latency in Morris Water Maze test.
Increased spontaneous alternation behavior in Y-maze task.
Increased Nissl-stained neurons in hippocampal CA1/DG and cortex.
Upregulated mAChR M1 expression in hippocampal CA1/DG and cortex.
Reduced TUNEL-positive cells in hippocampus and cortex to inhibit neuron apoptosis.
Lowered AChE activity and relative expression in hippocampus and cortex.
Suppressed caspase 3 and caspase 8 activity in hippocampus and cortex.
Decreased plasma IL-6 and TNF-α levels.
Decreased hippocampal p-Tau and HSP70 levels.
Increased hippocampal BDNF, Nrf2 expression and hippocampal mAChR M1 protein expression.
Reduced plasma AST, ALT, and ALP levels.
Chemical Information
-
Appearance Solid
-
Molecular Weight 339.37
-
Formula C18H13NO4S
-
Color Light yellow to brown
-
SMILES
O=C(S/C1=C/C2=CC=CC(O)=C2)N(C1=O)CC(C3=CC=CC=C3)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
DMSO : 125 mg/mL (368.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.9466 mL | 14.7332 mL | 29.4664 mL | 73.6659 mL |
| 5 mM | 0.5893 mL | 2.9466 mL | 5.8933 mL | 14.7332 mL | |
| 10 mM | 0.2947 mL | 1.4733 mL | 2.9466 mL | 7.3666 mL | |
| 15 mM | 0.1964 mL | 0.9822 mL | 1.9644 mL | 4.9111 mL | |
| 20 mM | 0.1473 mL | 0.7367 mL | 1.4733 mL | 3.6833 mL | |
| 25 mM | 0.1179 mL | 0.5893 mL | 1.1787 mL | 2.9466 mL | |
| 30 mM | 0.0982 mL | 0.4911 mL | 0.9822 mL | 2.4555 mL | |
| 40 mM | 0.0737 mL | 0.3683 mL | 0.7367 mL | 1.8416 mL | |
| 50 mM | 0.0589 mL | 0.2947 mL | 0.5893 mL | 1.4733 mL | |
| 60 mM | 0.0491 mL | 0.2456 mL | 0.4911 mL | 1.2278 mL | |
| 80 mM | 0.0368 mL | 0.1842 mL | 0.3683 mL | 0.9208 mL | |
| 100 mM | 0.0295 mL | 0.1473 mL | 0.2947 mL | 0.7367 mL |
Powered by Bioz